Medical Genetics: Genetic Mapping and Cloning Flashcards
Linkage v. Association (3)
- linkage is between loci
associations exist between diseases and specific alleles - linkage must be studied in families;
associations can be studied in unrelated persons - associations may imply a causal relationship; linkage does not
Strategy: Functional Approach
based on the knowledge of the specific gene product (protein) involved in the disease
ex. Hemoglobin
Strategy: Candidate Gene
based on the knowledge of the type of gene product involved in the disease.
*mapping not necessary
ex. For example, if a mutation in a ‘tyrosine kinase’ protein appears to be important in the pathogenesis of a disease, all known genes in the genome with a ‘tyrosine kinase’ domain could be evaluated for mutations in a set of affected and unaffected individuals
Strategy: Chromosomal abnormality
show that the disease is consistently associated with a cytogenetic abnormality such as a deletion or translocation.
microdeletion syndrome
ex. Prader Willi Syndrome
translocation-
Strategy: Positional Candidate (primary modern method)
- map disease to a chromosomal region (inheritance linkage analysis)
- survey plausible candidate genes in the region
ex. cystic fibrosis
ex. achondroplasia:
1. disease was mapped to short arm of chromosome 4 by linkage analysis
2. FGFR3 was known to be located in this region
Strategy: Next Generation DNA Sequencing (NGS)
exome or linkage interval
Exercise: Draw Products of Cross over
Take-Home: genes segregated independently if they are on different chromosomes or close on the same chromosome
50% Recombination: independent seg (no linkage)
0% Recombination: completely linked genes
LOD score cut-offs
pro-linkage: 3 or more
con-linkage: -2 or less
LOD= logarithm of odds
log (prob. of pedigree if linkage/ prob of pedigree if recombination)
genetic and physical maps
genetic: based on recombination?
physical: cytogenetic
complete nucleotide sequence: 3 billion base pairs per haploid genome)
next generation genome sequencing
Sequencing of exomes
The main strategies employed to identify a gene (or genes) with novel variants have been:
a. sequencing across multiple unrelated, affected individuals
b. sequencing multiple affected individuals from within a pedigree
c. sequencing parent–child trios; or comparing sequences of individuals from the extremes of the distribution for a quantitative phenotype.
More than 180 novel disease causing genes have been identified by now using this approach. A primary challenge of this technology is distinguishing between background polymorphisms and pathogenic mutations.